Ofev 150 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F1T75
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,794
Award facts
- Contract value 100% obligated
- $18,793.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,793.64 to AmerisourceBergen Drug Corp for the supply of OFEV 150 mg capsules (60-count units) on January 8, 2026, with a completion date of January 30, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract executed at the company's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems. The company maintains significant contracting relationships with the Defense Logistics Agency and other federal agencies, including the Department of Veterans Affairs and Defense Health Agency, delivering prescription medications across multiple therapeutic domains. OFEV (nintedanib) is an antifibrotic medication used to treat idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases, representing the type of specialty pharmaceutical product critical to military and veteran healthcare operations that AmerisourceBergen regularly provides through its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DR26F1T75?
SPE2DR26F1T75 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F1T75 worth?
The government has obligated $18,794 on SPE2DR26F1T75.
Is contract SPE2DR26F1T75 an order under another contract?
Yes. SPE2DR26F1T75 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T75 competed?
The extent of competition for SPE2DR26F1T75 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award